Bausch & Lomb (BLCO) Non-Current Deferred Tax Liability (2021 - 2026)

Bausch & Lomb (BLCO) posted Non-Current Deferred Tax Liability of $19.0 million for Q1 2026, little changed on a QoQ basis from $19.0 million in Q4 2025, and up 46.15% year-over-year from $13.0 million in Q1 2025.

Bausch & Lomb (BLCO) Non-Current Deferred Tax Liability (2021 - 2026) Analysis & Trends

Bausch & Lomb's Non-Current Deferred Tax Liability history runs 6 years deep, the most recent figure standing at $19.0 million for Q1 2026.

  • Quarterly Non-Current Deferred Tax Liability rose 46.15% year-over-year to $19.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $19.0 million (up 46.15% YoY) and the FY2025 annual result came in at $19.0 million, up 46.15% from the prior year.
  • Non-Current Deferred Tax Liability was $19.0 million for Q1 2026 at Bausch & Lomb, roughly flat from $19.0 million in the prior quarter.
  • Across five years, Non-Current Deferred Tax Liability topped out at $117.0 million in Q4 2022 and bottomed at $10.0 million in Q2 2022.
  • A 5-year average of $25.0 million and a median of $14.0 million in 2023 frame the typical range for Non-Current Deferred Tax Liability.
  • Annual changes were most pronounced in 2022 — Non-Current Deferred Tax Liability jumped 387.5% — and 2023, when it slumped 88.03%.
  • Bausch & Lomb's Non-Current Deferred Tax Liability stood at $117.0 million in 2022, then slumped by 88.03% to $14.0 million in 2023, then slipped by 7.14% to $13.0 million in 2024, then soared by 46.15% to $19.0 million in 2025, then changed by 0.0% to $19.0 million in 2026.
  • Business Quant data shows BLCO's Non-Current Deferred Tax Liability at $19.0 million in Q1 2026, $19.0 million in Q4 2025, and $14.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alcon 32,734,969.19 Bn 32,734,967.53 Bn 1.53 Bn
2 Intuitive Surgical 117.50 Bn 112.41 Bn 1.96 Bn
3 Becton Dickinson 42.93 Bn 42.11 Bn 2.15 Bn
4 Medline 30.82 Bn 36.66 Bn 1.84 Bn
5 Resmed 27.90 Bn 26.23 Bn 890.98 Mn
6 West Pharmaceutical Services 26.76 Bn 26.23 Bn 329.20 Mn
7 Cooper Companies 15.30 Bn 15.16 Bn 735.40 Mn
8 Solventum 13.46 Bn 12.90 Bn 1.10 Bn
9 Align Technology 12.02 Bn 10.96 Bn 736.59 Mn
10 Bausch & Lomb 5.68 Bn 5.47 Bn 973.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 19.00 Mn
Mar 31, 2026 19.00 Mn
Dec 31, 2025 19.00 Mn
Dec 31, 2025 19.00 Mn
Sep 30, 2025 14.00 Mn
Sep 30, 2025 14.00 Mn
Jun 30, 2025 14.00 Mn
Jun 30, 2025 14.00 Mn
Mar 31, 2025 13.00 Mn
Mar 31, 2025 13.00 Mn
Dec 31, 2024 13.00 Mn
Dec 31, 2024 13.00 Mn
Sep 30, 2024 12.00 Mn
Sep 30, 2024 12.00 Mn
Jun 30, 2024 14.00 Mn
Jun 30, 2024 14.00 Mn
Mar 31, 2024 14.00 Mn
Mar 31, 2024 14.00 Mn
Dec 31, 2023 14.00 Mn
Dec 31, 2023 14.00 Mn